The Benefits of VICH to Emerging Countries

Slides:



Advertisements
Similar presentations
17 September 2007ISO TC215 WG6 Brisbane1 Identification of Medicinal Products & Pharmacovigilance Task Forces.
Advertisements

GEO-5 in Ottawa 1 29 November 2004 Draft GEOSS 10-Year Implementation Plan and Status Report on Reference Document Ivan B. DeLoatch, Toshio Koike, Robert.
EPAA Conference 5 November 2007 Georgette LALIS Enterprise and Industry DG European Commission The international dimension of regulatory acceptance.
OIE First Global Conference on Veterinary Legislation 1 Control of Veterinary Products: The Need for Global Standards Merton V. Smith, Ph.D., J.D. Director,
OIE International Standards The OIE Standard Setting Process Regional Information Seminar for Recently Appointed OIE Delegates Brussels, Belgium, 18 –
Health and Consumers Health and Consumers Proposal for new EU Animal Health Regulation European Parliament, Intergroup on the welfare & conservation of.
Overview of ICH Procedures July 2015
APEC EWG 23 Bangkok, Thailand Earthquake Response Cooperation Program for Energy Supply Systems Phase 2 Progress Report By Chinese Taipei May 16, 2002.
FDA Public Meeting Preparation for the ICH Meetings in Tokyo, Japan, Including Progress on the Common Technical Document and Possibilities for New Topics.
First ARF Inter-sessional Meeting on non proliferation Beijing, China 1-3 July 2009 First ARF Inter-sessional Meeting on non proliferation Beijing, China.
WHO Regional Workshop on Good Manufacturing Practices for Blood Establishments Dr Ana Padilla, Blood Products & related Biologicals Essential Medicines.
Role of VICH and VICH guidelines in the approval process for veterinary medicinal products David Mackay, European Medicines Agency VICH Workshop – Dar.
Application of VICH GLs – extract from group discussion General: VICH GLs do not prescribe the data package to be submitted for registration, they merely.
JMAFF (Chair of Biologicals Quality Monitoring EWG)
VICH General Principles and current update of VICH Outreach Forum activity 1.
VICH Training Strategy Steven D. Vaughn, DVM Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine U.S. Food and Drug Administration.
Introduction to the VICH Outreach Forum Steven D. Vaughn, DVM VICH Workshop Dar Es Salaam, Tanzania – June 24, 2015.
Industry: trends, concerns hopes and ideas VICH5 Conference Carel du Marchie Sarvaas, Executive Director October 2015.
-What is VICH, History and Objectives Hervé MARION, DVM VICH Secretariat.
1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.
Session 3: How to use VICH GLs VICH5 Conference, October 2015, Tokyo 1.
The Benefits of VICH to VICH Member Countries and Regions DONALD A. PRATER, DVM Director, U.S. FDA Europe Office Office of International Programs Office.
VICH Outreach Forum OIE contribution 2 nd meeting of the Forum members Washington, 19 – 20 February 2013 S. Munstermann, JP Orand, C. Lambert.
Session 5: 3Rs statement VICH5 Conference, October 2015, Tokyo 1.
Link between legal framework of VMP regulation and VICH GLs in Japan Takashi Kozasa DVM Ministry of Agriculture, Forestry and Fisheries Government of Japan.
Session 9: The Vision for the Future 1 Dr. Yuko Endo JMAFF.
Session 7: VICH Conference
How to comment VICH guidelines Shixin XU, PhD, Prof. China IVDC.
VICH Task Force for Efficacy Studies for Combination Products Progress Report (Final) VICH members JMAFF (chair)K. Noda JVPAE. Oishi IFAH-EUM. Bobey EUK.
Slide 1 The contribution of a world-class regulatory environment to the future of the industry in Ireland Pat O’Mahony Chief Executive, Irish Medicines.
An agency of the European Union Consultation on draft VICH guidelines in the EU 2nd VICH Outreach Forum meeting, February 2013 Presented by: Kornelia.
1 THE OIE REPORT 32 nd VICH SC Meeting / 6 th VICH Outreach Forum Meeting Jean-Pierre Orand, Anses, France, OIE Collaborating Centre.
How to get involved in VICH Dr. Allen Bryce Independent consultant Canberra, Australia VICH Workshop: Dar Es Salaam, Tanzania – 24.
Waiving TABST for vaccines Argentina: Not an allowed procedure today Require batch safety tests in laboratory animals, repeated by authorities Currently.
4th VICH Outreach Forum June 2014, Brussels, belgium ASEAN Cooperation on Veterinary Products ASEAN National Focal Points on Veterinary Product.
1 1 Topics “out of the scope of VICH” Brigitte Boenisch IFAH-Europe 2 nd VICH Outreach Forum Meeting Washington, 19 th /20 th February 2012 – how and by.
1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating.
Issues Batch safety testing for vaccines
Update of Results of the Survey on training Priorities
POST APPROVAL CHANGE MANAGEMENT PROTOCOLS IN THE EUROPEAN UNION
VICH Public Conference 6: February 2019 INVITATION TO VOF MEMBERS
Hervé Marion, DVM VICH Secretariat
VICH General Principles and
Commenting on VICH Guidelines in Australia & New Zealand
Ministry of Industry and Commerce
The OIE report 30th VICH SC Meeting / 4th VICH Outreach Forum Meeting
Michelle Limoli, Pharm.D.
Veterinary Pharmacovigilance Discussion
The Vision for the Future
Report by the VICH Steering Committee on issues raised by Forum members during the 1st Outreach Forum meeting Hervé Marion, DVM VICH Secretariat.
ASEAN Harmonisation Update: Progress Towards Finalisation & Challenges Daniel Quek Chairman, ASEAN Alliance of Health Supplement Associations Anaheim.
Multinational collaboration in the Authorisation of VMPs: the EU approach VICH Outreach Forum Tokyo, Nov 2017 Noel Joseph European Commission.
Minor Uses A North American Perspective
Animal welfare policies and standards of the OIE
Waiving Target Animal Batch Safety Testing for vaccines
Dr Elisabeth Erlacher-Vindel,
Emerging Policy Issues Nanotechnologies and manufactured nanomaterials
Animal welfare policies and standards of the OIE
Consultation on VICH Concept Papers and Draft Guidelines
The expectations from VICH Outreach Forum members
How Can I Get More Information on VICH?
Introduction to the Proposed Philippine Code of Practice for Cacao
GL50(R)- HARMONISATION OF CRITERIA TO WAIVE TARGET ANIMAL BATCH SAFETY TESTING FOR INACTIVATED VACCINES FOR VETERINARY USE ( May 2017) GL55- HARMONISATION.
Developments in the EU medicines regulatory network
Recommendations to facilitate assessment of new application procedures
Summary: 38th JSTC Meeting Sep 15 & 17, 2010 Kobe, Japan
OIE’s standard setting process
Promotion of Agricultural Products
Hervé Marion, DVM VICH Secretariat
Session 1 - Agenda Item 5.: OIE
Presentation transcript:

The Benefits of VICH to Emerging Countries Dr.Sasi Jaroenpoj ,DVM Department of Livestock Development THAILAND 27 – 29 October 2015 (Tokyo, Japan)

Why Participate in VICH ? (Benefits) Update activities

WHY Participate in ?

Primary Benefits of VICH Use of Internationally harmonised guidelines to; Ensure product quality, safety and efficacy Reduce animal testing and costs of development Accelerate the development and reviewing process Increase availability of new VMPs Contribute to animal/public health, environment Unique opportunity for; Regulators and industry to discuss regulatory data requirements Discussion between worldwide scientific experts

Secondary Benefits of VICH Better understanding of regulations and concerns in the other regions Opportunity to update regional regulations A basis for future global harmonisation of registration guidelines Opportunity to discuss emerging global issues and relevant science Contribute to the Global One Health approach

Latest VOF topics (2014)-1 Report on the development of a training and communication strategy, Outlining VICH’s current thoughts, and requesting feedback from the VOF members; Progress reports of the Task Forces Revision of the guideline on stability : in Climate Zone III and IV (hot and hot/humid climates) New guideline on efficacy for combination products originally proposed by China

Latest VOF topics (2014)-2 Presentation - Links between the legal frameworks for VMPs and VICH GLs in Japan, Canada and EU - ASEAN Cooperation on Veterinary Medicinal Products Training presentations Generics : definitions and related terms Technical aspects of bioequivalence Waiving of target animal batch safety testing How to comment on VICH guideline

Latest VOF topics (2014) -3 Updates from VICH Outreach Forum participants Implementation of VICH guidelines National/Regional activities regarding VMPs Group discussions of questions to VOF members and feedback to the SC

Latest VOF topics (2015)-1 Report on the development of a training and communication strategy, Many materials available on the VICH public website SC will discuss to identify funding opportunity to support VICH level 2 training program Progress reports of the SC Not develop GL on efficacy study for combination products containing antimicrobial substances (scope anthelmintic) Develop GL on stability in climate zone III and IV separate from existing GL (ultimate goal for non-VICH countries) (CAMEVET will provide its expertise to the EWG)

Latest VOF topics (2015)-2 Group discussion Topic TABST and Bioequivalence Application of VICH GLs Information from CAMEVET : details member countries that use the original or modified VICH GLs China : existing Chinese GLs will be modified to include the VICH GL elements Thailand : Will propose some GLs to consider at the next ASEAN meeting

Latest VOF topics (2015)-3 Participation in VICH process The procedure for the registration of animal vaccines in ASEAN How to comment on a draft VICH GL OIE confirmed that the drafted GL are circulated each time with request for comment CAMEVET sends the drafted GL to its focal point in its member countries China translated into chinese and distributed to 10 experts to provide their comment within 10 working days . National focal point send them to VICH secretariat

Latest VOF topics (2015)-4 Training presentations GLP/GCP requirement and implementation EU explained how Pharmacovigilance systems and processes are developed Topic propose for next presentation Aquaculture product and VICH MRL GL for fish and honey Herbal medicine Review of AMR GL 27,Anthelmintic GL Implementation of TABST in the 3 VICH regions Bioequivalence and generic policy Training strategy

How to access to VICH Outreach Forum member area Write to the VICH secretariat: sec@vichsec.org for ASEAN National focal point!

Thank You Very Much for Your Attention Emerging response for Your Attention Department of Livestock Development